Sessions & Session Chairs

Sessions

S1. Immune System, Tumor Immunology and Autoimmune Disease
S2. Diabetes, Obesity and Metabolic Diseases
S3. Neuroscience and Neurodegeneration
S4. Cardiology and Cardiovascular Diseases
S5. Cancer Molecular Biology and Precision Medicine
S6. Bone Biology and Regenerative Medicine
S7. Translational Medicine and Nanomedicine
S8. AI in Biomedicines
Assoc. Prof. Allan Stensballe
Session chair
Honorary Associate Professor, Australian National Phenome Centre, Murdoch University, Australia
Assoc. Prof. Dr. Allan Stensballe is a prominent figure in the fields of proteomics, systems biology, inflammation, biomarker discovery, and omics data analysis. His expertise is deeply rooted in proteomics and the application of proteomics for understanding human disease pathology, especially in the context of precision medicine. He has played a key role in leading precision health research initiatives, fostering technology-driven innovation and strengthening collaboration between academia and industry to address important challenges in global health and wellness.
Dr. Maria-Ioanna (Marianna) Christodoulou
Session chair
Department of Life Sciences, European University Cyprus, Nicosia 2404, Cyprus, School of Infection and Immunity, University of Glasgow, Glasgow G12 8TA, UK
Dr. Maria-Ioanna (Marianna) Christodoulou is affiliated with the Department of Life Sciences at European University Cyprus and the School of Infection and Immunity at the University of Glasgow. Her research focuses on immunology and cancer, particularly exploring how the immune system interacts with tumor cells to influence cancer progression and treatment outcomes. She is engaged in collaborative research between Cyprus and the UK, contributing to advancements in cancer immunotherapy.

Prof. Dr. Serafino Fazio
Session chair
Internal Medicine, Federico II University School of Medicine, Naples, Italy
Dr. Serafino Fazio obtained his MD in Medicine and Surgery from the University of Naples Federico II in 1974 and subsequently specialized in Internal Medicine and Cardiology. He served as a university researcher and later as Associate Professor of Internal Medicine at the University of Naples Federico II, School of Medicine, from 1975 to 2012, and is now retiredDr. Fazio has authored over 170 publications in leading journals, including The New England Journal of Medicine, Nature Medicine, Annals of Internal Medicine, and Circulation. His research interests include the interaction between hormones and the cardiovascular system, heart failure, metabolic syndrome, nutraceuticals, and, more recently, COVID-19 treatment. His H-index is 49 (Google Scholar).

Dr. Qin Fu
Session chair
Proteomics and Metabolomics Facility, Cornell University, 526 campus road, Ithaca, NY, USA
Dr. Qin Fu specializes in LC-MS/MS, proteomics, peptidomics, and metabolomics. His research focuses on advanced mass spectrometry applications for biomolecular analysis and systems biology. He has an H-index of 17 and contributes to interdisciplinary biotechnology and analytical chemistry research.

Prof. Dr. Jianping Li
Session chair
Department of Cardiology at Peking University First Hospital, Beijing, China
Prof. Dr. Jianping Li is a cardiovascular medicine specialist with extensive expertise in clinical cardiology and cardiovascular research. His work focuses on improving the prevention, diagnosis, and treatment of cardiovascular diseases.

Prof. Dr. Georgia Levidou
Session chair
Department of Pathology, Paracelsus medical University, Nuremberg, Germany
Prof. Dr. Georgia Levidou is a consultant Pathologist at the Department of Pathology, Paracelsus medical university in Nuremberg, Germany. She received her medical degree (MD), PhD and MSc in Biostatistics at the University of Athens, Greece. She has a twenty years’ experience on pathology and research acquired in leading research centers and is an author of more than 87 peer-reviewed articles. Her research interests span both cancer diagnostics, cellular and molecular pathology as well as tumor prognostic and therapeutic biomarkers. Prof. Levidou has a special interest in hematopathology and is currently working especially on the field of thymic epithelial tumors.
Dr. Chun Ming Wong
Session chair
Department of Pathology The University of Hong Kong Pokfulam, Hong Kong, China
Dr. Chun Ming Wong is affiliated with the Department of Pathology at The University of Hong Kong. His research focuses on molecular pathology, cancer biology, and translational medicine, with particular interest in the molecular mechanisms underlying tumor development and progression. He has contributed to numerous peer-reviewed publications and is actively involved in advancing research and education in pathology.

Assoc. Prof. Stefano Bacci
Session chair
Department of Biology, University of Florence, 50121 Florence, Italy
Assoc. Prof. Dr. Stefano Bacci specializes in wound healing, acute and chronic wounds, lesion vitality, mast cells, and dendritic cells. His research focuses on tissue repair and inflammatory responses in histology and embryology, contributing extensively to biomedical and regenerative research.

Prof. Dr. Matthew Pincus
Session chair
SUNY Downstate Medical Center, SUNY Downstate Health Sciences University New York, USA.
Prof. Matthew R. Pincus specializes in biochemistry, genetics, molecular biology, medicine, chemistry, immunology, microbiology, pharmacology, toxicology, and materials science. His research focuses on interdisciplinary biomedical sciences and cancer-related studies, contributing extensively to molecular medicine and translational health research.
Prof. Dr. Songwei Tan
Session chair
School of Pharmacy, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China
Prof. Dr. Songwei Tan is a Professor in Pharmaceutics at Tongji School of Pharmacy, Huazhong University of Science and Technology. His research focuses on biomedical polymer materials and novel drug delivery systems. He has led multiple national and local research projects, published over 30 SCI papers (4 ESI highly cited), and holds 3 invention patents. His work aims to advance innovative pharmaceutical formulations for clinical applications.
Prof. Dr. Hongxu Lu
Session chair
Shanghai Institute of Ceramics, Chinese Academy of Sciences, China
Prof. Dr. Hongxu Lu is specializing in organoids, organ-on-chip systems, biomaterials, and regenerative medicine. His work focuses on developing advanced in vitro models and bioactive materials for biomedical applications.

Assoc. Prof. Yadi Wu
Session chair
University of Kentucky, Department of Pharmacology and Nutritional Sciences, Lexington
Assoc. Prof. Dr. Yadi Wu is an Associate Professor in the Department of Pharmacology and Nutritional Sciences at the University of Kentucky College of Medicine and a researcher at the Markey Cancer Center. Her research focuses on cancer biology, particularly breast cancer metastasis, tumor microenvironment, and epigenetic regulation. Her work has contributed to understanding key molecular pathways involved in cancer progression and immune evasion, with the goal of identifying new therapeutic targets for cancer treatment
Prof. Dr. Yuanshan Zhu
Session chair
Clinical and Translational Science Center(CTSC), Department of Medicine, Weill Cornell Medicine, New York, NY 10065, USA
Dr. Yuanshan Zhu specializes in long non-coding RNAs (lncRNAs), prostate cancer, and molecular genetics. His research focuses on the role of noncoding RNAs in gene regulation and human diseases, contributing extensively to molecular and translational medicine research.
Assoc. Prof. Ping  Mu
Session chair
Assoc. Prof. Ping Mu
Department of Urology and Pathology, Yale Biomedical Imaging Institute, Yale School of Medicine, USA
Dr. Ping Mu is an Associate Professor at Yale University specializing in cancer biology, prostate cancer, and therapeutic resistance mechanisms. His research integrates organoids, single-cell sequencing, spatial transcriptomics, and AI-driven omics approaches to develop innovative cancer therapies. In 2025, he received the Prostate Cancer Foundation Challenge Award for research on long-term remission and adoptive cell immunotherapy in metastatic prostate cancer.


Powered by Sciforum
Disclaimer
Terms and ConditionsPrivacy PolicyAccessibility